Superior cancer therapeutics using transformative innovations

Safer with less side effects for patients

Next-generation ADCs and novel antibody formats will take safety to the next level

Building a unique pipeline

With a strong foundation in ADCs and our lead program in clinical studies in AML

A team pushing the boundaries

The VERAXA team is constantly evolving its technology suite to build better and safer medicines
learn more